Financhill
Buy
52

MCD Quote, Financials, Valuation and Earnings

Last price:
$291.00
Seasonality move :
3.14%
Day range:
$289.30 - $296.10
52-week range:
$243.53 - $317.90
Dividend yield:
2.32%
P/E ratio:
25.70x
P/S ratio:
8.17x
P/B ratio:
--
Volume:
7M
Avg. volume:
3.1M
1-year change:
1.28%
Market cap:
$209.7B
Revenue:
$25.5B
EPS (TTM):
$11.39
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $21.4B $19.2B $23.2B $23.2B $25.5B
Revenue Growth (YoY) 0.5% -10.09% 20.9% -0.17% 9.97%
 
Cost of Revenues $10.2B $9.5B $10.6B $10B $10.9B
Gross Profit $11.2B $9.8B $12.6B $13.2B $14.6B
Gross Profit Margin 52.33% 50.77% 54.17% 56.97% 57.12%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $2B $2.2B $2.4B $2.5B $2.4B
Other Inc / (Exp) $153M $134.5M $432.3M -$1.4B -$48.9M
Operating Expenses $2.2B $2.5B $2.7B $2.9B $2.8B
Operating Income $9B $7.2B $9.9B $10.3B $11.7B
 
Net Interest Expenses $1.1B $1.2B $1.2B $1.2B $1.2B
EBT. Incl. Unusual Items $8B $6.1B $9.1B $7.8B $10.5B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $2B $1.4B $1.6B $1.6B $2.1B
Net Income to Company $6B $4.7B $7.5B $6.2B $8.5B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $6B $4.7B $7.5B $6.2B $8.5B
 
Basic EPS (Cont. Ops) $7.95 $6.35 $10.11 $8.39 $11.63
Diluted EPS (Cont. Ops) $7.88 $6.31 $10.04 $8.33 $11.56
Weighted Average Basic Share $758.1M $744.6M $746.3M $736.5M $727.9M
Weighted Average Diluted Share $764.9M $750.1M $751.8M $741.3M $732.3M
 
EBITDA $10.8B $9.1B $12.2B $10.9B $13.9B
EBIT $9.1B $7.4B $10.3B $9B $11.9B
 
Revenue (Reported) $21.4B $19.2B $23.2B $23.2B $25.5B
Operating Income (Reported) $9B $7.2B $9.9B $10.3B $11.7B
Operating Income (Adjusted) $9.1B $7.4B $10.3B $9B $11.9B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $5.4B $6.2B $5.9B $6.7B $6.9B
Revenue Growth (YoY) -1.53% 14.46% -5.31% 13.96% 2.72%
 
Cost of Revenues $2.5B $2.8B $2.4B $2.8B $3B
Gross Profit $2.9B $3.4B $3.4B $3.9B $3.9B
Gross Profit Margin 53.61% 55.33% 58.69% 57.74% 56.39%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $454.7M $559.6M $576.4M $584M $536M
Other Inc / (Exp) $149.6M $195.1M $55.2M $33M -$22M
Operating Expenses $530.5M $643.7M $669.7M $681M $647M
Operating Income $2.4B $2.8B $2.8B $3.2B $3.2B
 
Net Interest Expenses $306.7M $291.4M $295.4M $294M $363M
EBT. Incl. Unusual Items $2.2B $2.7B $2.5B $2.9B $2.8B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $454.5M $541.5M $554.6M $606M $588M
Net Income to Company $1.8B $2.1B $2B $2.3B $2.3B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $1.8B $2.1B $2B $2.3B $2.3B
 
Basic EPS (Cont. Ops) $2.37 $2.88 $2.70 $3.19 $3.15
Diluted EPS (Cont. Ops) $2.35 $2.86 $2.68 $3.17 $3.13
Weighted Average Basic Share $744.5M $747.1M $734.9M $727.2M $716.7M
Weighted Average Diluted Share $750M $752.6M $739.5M $731.6M $720M
 
EBITDA $3B $3.5B $3.3B $3.8B $3.8B
EBIT $2.5B $3B $2.8B $3.3B $3.2B
 
Revenue (Reported) $5.4B $6.2B $5.9B $6.7B $6.9B
Operating Income (Reported) $2.4B $2.8B $2.8B $3.2B $3.2B
Operating Income (Adjusted) $2.5B $3B $2.8B $3.3B $3.2B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $19.3B $22.5B $23.3B $25B $25.9B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $9.5B $10.4B $10.2B $10.7B $11.3B
Gross Profit $9.8B $12.1B $13.1B $14.3B $14.7B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $2.1B $2.3B $2.5B $2.4B $2.5B
Other Inc / (Exp) $89.8M $583.2M -$1.4B $9.2M -$148.9M
Operating Expenses $2.4B $2.6B $2.9B $2.8B $2.9B
Operating Income $7.4B $9.5B $10.2B $11.5B $11.8B
 
Net Interest Expenses $1.2B $1.2B $1.2B $1.2B $1.3B
EBT. Incl. Unusual Items $6.3B $8.9B $7.6B $10.3B $10.3B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $1.4B $1.6B $1.7B $2B $2.1B
Net Income to Company $4.9B $7.3B $5.9B $8.3B $8.2B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $4.9B $7.3B $5.9B $8.3B $8.2B
 
Basic EPS (Cont. Ops) $6.62 $9.76 $8.00 $11.43 $11.45
Diluted EPS (Cont. Ops) $6.55 $9.70 $7.94 $11.36 $11.39
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA $9.3B $11.9B $10.7B $13.6B $13.8B
EBIT $7.6B $10B $8.8B $11.7B $11.8B
 
Revenue (Reported) $19.3B $22.5B $23.3B $25B $25.9B
Operating Income (Reported) $7.4B $9.5B $10.2B $11.5B $11.8B
Operating Income (Adjusted) $7.6B $10B $8.8B $11.7B $11.8B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $13.9B $17.2B $17.3B $19.1B $19.5B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $6.9B $7.9B $7.5B $8.2B $8.5B
Gross Profit $7B $9.3B $9.8B $10.9B $11B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $1.5B $1.6B $1.8B $1.7B $1.7B
Other Inc / (Exp) $1.5M $450.2M -$1.4B -$29M -$127M
Operating Expenses $1.8B $1.9B $2.1B $2B $2.1B
Operating Income $5.2B $7.5B $7.7B $8.9B $9B
 
Net Interest Expenses $895.4M $883.7M $866.1M $879M $1B
EBT. Incl. Unusual Items $4.3B $7B $5.5B $8B $7.8B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $957.4M $1.1B $1.2B $1.6B $1.6B
Net Income to Company $3.4B $5.9B $4.3B $6.4B $6.2B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $3.4B $5.9B $4.3B $6.4B $6.2B
 
Basic EPS (Cont. Ops) $4.51 $7.91 $5.80 $8.83 $8.63
Diluted EPS (Cont. Ops) $4.47 $7.86 $5.76 $8.77 $8.59
Weighted Average Basic Share $2.2B $2.2B $2.2B $2.2B $2.2B
Weighted Average Diluted Share $2.2B $2.3B $2.2B $2.2B $2.2B
 
EBITDA $6.5B $9.3B $7.8B $10.5B $10.5B
EBIT $5.2B $7.9B $6.4B $9B $8.9B
 
Revenue (Reported) $13.9B $17.2B $17.3B $19.1B $19.5B
Operating Income (Reported) $5.2B $7.5B $7.7B $8.9B $9B
Operating Income (Adjusted) $5.2B $7.9B $6.4B $9B $8.9B
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $898.5M $3.4B $4.7B $2.6B $4.6B
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $2.2B $2.1B $1.9B $2.1B $2.5B
Inventory $50.2M $51.1M $55.6M $52M $52.8M
Prepaid Expenses -- -- -- -- --
Other Current Assets $385M $632.7M $511.3M $673.4M $866.3M
Total Current Assets $3.6B $6.2B $7.1B $5.4B $8B
 
Property Plant And Equipment $37.4B $38.8B $38.3B $36.3B $38.4B
Long-Term Investments $1.3B $1.3B $1.2B $1.1B $1.1B
Goodwill $2.7B $2.8B $2.8B $2.9B $3B
Other Intangibles -- -- -- -- --
Other Long-Term Assets $2.6B $3.5B $4.4B $4.7B $5.6B
Total Assets $47.5B $52.6B $53.9B $50.4B $56.1B
 
Accounts Payable $988.2M $741.3M $1B $980.2M $1.1B
Accrued Expenses $1.4B $1.5B $1.7B $1.6B $1.9B
Current Portion Of Long-Term Debt $59.1M $2.2B -- -- $2.2B
Current Portion Of Capital Lease Obligations $621M $701.5M $705.5M $661.1M $688.1M
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $3.6B $6.2B $4B $3.8B $6.9B
 
Long-Term Debt $34.1B $35.2B $35.6B $35.9B $37.2B
Capital Leases -- -- -- -- --
Total Liabilities $55.7B $60.5B $58.5B $56.4B $60.9B
 
Common Stock $16.6M $16.6M $16.6M $16.6M $16.6M
Other Common Equity Adj -$2.5B -$2.6B -$2.6B -$2.5B -$2.5B
Common Equity -$8.2B -$7.8B -$4.6B -$6B -$4.7B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity -$8.2B -$7.8B -$4.6B -$6B -$4.7B
 
Total Liabilities and Equity $47.5B $52.6B $53.9B $50.4B $56.1B
Cash and Short Terms $898.5M $3.4B $4.7B $2.6B $4.6B
Total Debt $34.2B $37.4B $35.6B $35.9B $39.3B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $3.7B $4.3B $2.8B $3.5B $1.2B
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $2.4B $1.8B $1.9B $2.2B $2.5B
Inventory $44.2M $50.1M $43.4M $47.6M $54M
Prepaid Expenses -- -- -- -- --
Other Current Assets $616.3M $611.5M $979.2M $1.1B $1.2B
Total Current Assets $6.7B $6.8B $5.7B $6.9B $4.9B
 
Property Plant And Equipment $37.5B $38B $34.9B $36.2B $39.4B
Long-Term Investments $1.3B $1.2B $963.8M $1B $3B
Goodwill $2.7B $2.7B $2.7B $3B $3.2B
Other Intangibles -- -- -- -- --
Other Long-Term Assets $2.5B $4.1B $4.3B $5.1B $5.7B
Total Assets $50.7B $52.7B $48.5B $52.1B $56.2B
 
Accounts Payable $689M $772.6M $794.8M $862.4M $944M
Accrued Expenses $1.6B $1.6B $1.4B $1.7B $1.8B
Current Portion Of Long-Term Debt $2.7B $500M -- -- $596M
Current Portion Of Capital Lease Obligations $718.2M $701.5M $654.9M $668.1M $668M
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $6.3B $5.1B $3.5B $4B $6.3B
 
Long-Term Debt $35.1B $34.6B $34.9B $37.3B $39B
Capital Leases -- -- -- -- --
Total Liabilities $59.2B $58.4B $55.1B $56.9B $61.3B
 
Common Stock $16.6M $16.6M $16.6M $16.6M $17M
Other Common Equity Adj -$2.8B -$2.7B -$2.6B -$2.5B -$2.3B
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity -$8.5B -$5.7B -$6.6B -$4.9B -$5.2B
 
Total Liabilities and Equity $50.7B $52.7B $48.5B $52.1B $56.2B
Cash and Short Terms $3.7B $4.3B $2.8B $3.5B $1.2B
Total Debt $37.8B $35.1B $34.9B $37.3B $39.6B
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders $6B $4.7B $7.5B $6.2B $8.5B
Depreciation & Amoritzation $1.6B $1.8B $1.9B $1.9B $2B
Stock-Based Compensation $109.6M $92.4M $139.2M $166.7M $175.2M
Change in Accounts Receivable $27M -$6.8M $309.9M -$264.1M -$161M
Change in Inventories $128.8M -$68.6M -$62.2M $5.6M $16.7M
Cash From Operations $8.1B $6.3B $9.1B $7.4B $9.6B
 
Capital Expenditures $2.4B $1.6B $2B $1.9B $2.4B
Cash Acquisitions -$200.1M $10.2M -$178M -$361.1M -$245.9M
Cash From Investing -$3.1B -$1.5B -$2.2B -$2.7B -$3.2B
 
Dividends Paid (Ex Special Dividend) -$3.6B -$3.8B -$3.9B -$4.2B -$4.5B
Special Dividend Paid
Long-Term Debt Issued $4.5B $5.5B $1.2B $3.4B $5.2B
Long-Term Debt Repaid -$2.1B -$2.4B -$2.2B -$2.2B -$2.4B
Repurchase of Common Stock -$5B -$907.8M -$845.5M -$3.9B -$3.1B
Other Financing Activities -$23.5M -$122M -$46.7M $38.2M -$39.6M
Cash From Financing -$5B -$2.2B -$5.6B -$6.6B -$4.4B
 
Beginning Cash (CF) $866M $898.5M $3.4B $4.7B $2.6B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $56.2M $2.5B $1.4B -$1.9B $2.1B
Ending Cash (CF) $898.5M $3.4B $4.7B $2.6B $4.6B
 
Levered Free Cash Flow $5.7B $4.6B $7.1B $5.5B $7.3B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $1.8B $2.1B $2B $2.3B $2.3B
Depreciation & Amoritzation $440.1M $469.2M $465.6M $498M $532M
Stock-Based Compensation $7.3M $34.1M $38.3M $43M $40M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $2.9B $2.6B $2.4B $3B $2.7B
 
Capital Expenditures $390.2M $501.5M $531.2M $570M $794M
Cash Acquisitions $1.3M $31.5M -$119.2M -$76M -$379M
Cash From Investing -$267.9M -$384.9M -$733.1M -$933M -$1.3B
 
Dividends Paid (Ex Special Dividend) -$930.9M -$963.9M -$1B -$1.1B -$1.2B
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $2.8M -- $1.5B $2B --
Long-Term Debt Repaid -$451.5M -$400K -$400K -- --
Repurchase of Common Stock -$700K -$17.7M -$869.2M -$1.1B -$469M
Other Financing Activities -$100K -$11.7M $80.9M -$41M -$27M
Cash From Financing -$2.3B -$927.4M -$546.4M -$136M -$1.1B
 
Beginning Cash (CF) $3.3B $3B $1.9B $1.6B $792M
Foreign Exchange Rate Adjustment $25M -$49.1M -$198.6M -$89M $46M
Additions / Reductions $403.1M $1.3B $1.2B $2B $383M
Ending Cash (CF) $3.7B $4.3B $2.8B $3.5B $1.2B
 
Levered Free Cash Flow $2.5B $2.1B $1.9B $2.5B $1.9B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $4.9B $7.3B $5.9B $8.3B $8.2B
Depreciation & Amoritzation $1.7B $1.9B $1.9B $1.9B $2B
Stock-Based Compensation $83.5M $126.3M $172.2M $173.8M $165.2M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $6.2B $8.5B $7.9B $9.3B $9.3B
 
Capital Expenditures $1.9B $1.8B $2.1B $2.1B $2.7B
Cash Acquisitions -$29.7M $49.9M -$151.4M -$620.9M -$2.3B
Cash From Investing -$2B -$1.4B -$2.7B -$3.4B -$5.4B
 
Dividends Paid (Ex Special Dividend) -$3.7B -$3.9B -$4.1B -$4.4B -$4.8B
Special Dividend Paid
Long-Term Debt Issued $5.5B -- $4.5B $3.1B $3.9B
Long-Term Debt Repaid -$1.4B -$2.7B -$2.7B -$1.4B -$2.8B
Repurchase of Common Stock -$2.4B -$44.4M -$4.2B -$2.7B -$3.2B
Other Financing Activities -$122M -$32.7M $34.7M -$17.5M -$58.6M
Cash From Financing -$1.8B -$6.4B -$6.2B -$5.3B -$6.2B
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $2.4B $628.7M -$1B $602.1M -$2.3B
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $4.3B $6.7B $5.8B $7.2B $6.6B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $3.4B $5.9B $4.3B $6.4B $6.2B
Depreciation & Amoritzation $1.3B $1.4B $1.4B $1.5B $1.5B
Stock-Based Compensation $64M $97.9M $130.9M $138M $128M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $4.3B $6.5B $5.2B $7.1B $6.8B
 
Capital Expenditures $1.2B $1.4B $1.4B $1.6B $2B
Cash Acquisitions -$14.5M $25.2M $51.8M -$208M -$2.3B
Cash From Investing -$1.2B -$1B -$1.6B -$2.3B -$4.6B
 
Dividends Paid (Ex Special Dividend) -$2.8B -$2.9B -$3.1B -$3.3B -$3.6B
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $5.5B -- $3.4B $3.1B $1.7B
Long-Term Debt Repaid -$1.4B -$1.7B -$2.2B -$1.4B -$1.8B
Repurchase of Common Stock -$905.6M -$42.2M -$3.4B -$2.2B -$2.3B
Other Financing Activities -$122M -$32.7M $48.7M -$7M -$26M
Cash From Financing -$313.4M -$4.5B -$5.1B -$3.8B -$5.6B
 
Beginning Cash (CF) $9.5B $9.5B $8.9B $7.9B $6.2B
Foreign Exchange Rate Adjustment $9.2M -$77.7M -$396.2M -$77M $47M
Additions / Reductions $2.8B $934.4M -$1.5B $989M -$3.4B
Ending Cash (CF) $12.3B $10.4B $7B $8.8B $2.9B
 
Levered Free Cash Flow $3.1B $5.1B $3.8B $5.5B $4.8B

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 23

Quantum [QMCO] is down 0.37% over the past day.

Sell
46
NUKK alert for Dec 23

Nukkleus [NUKK] is up 7.53% over the past day.

Sell
1
IIPR alert for Dec 23

Innovative Industrial Properties [IIPR] is down 6.19% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock